. . "Xijian Li" . . . . . . . . . . . . . "wetenschappelijk artikel"@nl . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@nl . . . . "6668024" . . . . . "10.1021/ACS.JMEDCHEM.8B00498" . . "Jiean Chen" . . . . . . . . . "Sheng Tian" . . . . "Jean J Zhao" . . . . . . . . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@nl . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@nl . . . . "Jing Ni" . . . . . . . . . . . . . . . . . "Miyang Li" . . "Peichen Pan" . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@en . . "8613-8624" . "Huidong Yu" . "im September 2018 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . . . . . . . . "19" . . . . "article"@en . . . . . . . . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u0432\u0435\u0440\u0435\u0441\u043D\u0456 2018"@uk . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@en . . "30227711" . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@en . . "2018-09-27T00:00:00Z"^^ . . . . "Xuwen Wang" . . "61" . . . . . "Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo"@en . . . . . . . .